RxDoctor Payments DataLook up a doctor →

Stanislav Tolkachjov, MD

Dermatology · Lewisville, TXNPI 1952662868

Payments from drug & device makers

$388,455in general payments, 2019–2025

Across 530 payments — averaging $732.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$170K
  • Kerecis Limited$67K
  • Regeneron$49K
  • Misonix Inc$34K
  • Bioventus LLC$31K
  • Boehringer Ingelheim International GmbH$22K
  • plus $17K from 33 others
$36,765in research payments, 2019–2025

Across 10 payments — averaging $3676.47 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bioventus LLC$35K
  • Regeneron$1K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$388,455 in reported general payments places this provider in the 95th percentile of 1,098 dermatology providers in Texas.

See all dermatology providers in Texas

Medicare billing

Part B allowed, 2024
$1,117,274
Medicare patients
879
Services billed
3,405

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatology in Lewisville

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →